Operating Income: The income after operating expenses.
Genocea Biosciences, Inc. (GNCAQ) had Operating Income of $-15.77M for the most recently reported fiscal quarter, ending 2022-03-31.
| Income Statement Financials | |
$0.27M |
|
$-15.98M |
|
-- |
|
$0.27M |
|
$16.04M |
|
|
Operating Income |
$-15.77M |
$-0.20M |
|
$-15.98M |
|
$-15.98M |
|
$-15.98M |
|
$-15.98M |
|
$-15.98M |
|
$-15.98M |
|
$-15.77M |
|
$-15.37M |
|
71.12M |
|
71.12M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$24.41M |
|
$6.56M |
|
$14.38M |
|
$38.79M |
|
$18.03M |
|
$2.95M |
|
$8.37M |
|
$26.40M |
|
$12.38M |
|
$12.38M |
|
$12.38M |
|
58.73M |
|
| Cash Flow Statement Financials | |
$-15.21M |
|
$-0.94M |
|
$-0.86M |
|
$37.78M |
|
$20.77M |
|
$-17.01M |
|
$0.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.35 |
|
-- |
|
-- |
|
0.19 |
|
0.62 |
|
100.00% |
|
-5841.85% |
|
-5841.85% |
|
-- |
|
-5917.78% |
|
-5917.78% |
|
$-16.15M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-129.01% |
|
-129.01% |
|
-41.19% |
|
-104.21% |
|
$0.21 |
|
$-0.23 |
|
$-0.21 |
|